APA (7th ed.) Citation

P, B., N, D., J, B., C, D., E, G., D, S., . . . N, M. (2026). Dual Antiplatelet Therapy beyond 1 Year after a Myocardial Infarction Compared with Low-Dose Aspirin Alone: A 3-Year Follow-Up Cohort Study Within the French SNDS Nationwide Claims Database. American journal of cardiovascular drugs : drugs, devices, and other interventions, 26(3), 359. https://doi.org/10.1007/s40256-025-00782-5

Chicago Style (17th ed.) Citation

P, Blin, Danchin N, Benichou J, Dureau-Pournin C, Guiard E, Sakr D, Jové J, Lassalle R, and Moore N. "Dual Antiplatelet Therapy Beyond 1 Year After a Myocardial Infarction Compared with Low-Dose Aspirin Alone: A 3-Year Follow-Up Cohort Study Within the French SNDS Nationwide Claims Database." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 26, no. 3 (2026): 359. https://doi.org/10.1007/s40256-025-00782-5.

MLA (9th ed.) Citation

P, Blin, et al. "Dual Antiplatelet Therapy Beyond 1 Year After a Myocardial Infarction Compared with Low-Dose Aspirin Alone: A 3-Year Follow-Up Cohort Study Within the French SNDS Nationwide Claims Database." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, vol. 26, no. 3, 2026, p. 359, https://doi.org/10.1007/s40256-025-00782-5.